Dermatology Drugs Pharma Companies 
pharmaphorum
SEPTEMBER 15, 2022
The competition authorities in Switzerland said this morning they have carried out a raid on a pharma company – now confirmed to be Novartis – as part of an investigation into a “possible unlawful use of a patent to reduce competitive pressure.”
XTalks
JULY 16, 2021
Related: Google Launches AI-Based Dermatology Assist Tool. In fact, benzene is one of the 20 most widely used chemicals in the US, serving as a starting material for making plastics, dyes, rubbers, drugs and pesticides. Benzene is a colorless flammable liquid that has a sweet odor. Despite this, contamination issues still persist.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
FEBRUARY 1, 2021
Almirall is a specialist in psoriasis therapies with drugs like Skilarence (dimethyl fumarate) and Ilumetri (tildrakizumab), while Happify’s app is designed to drive away negative thoughts through the use of games, mindfulness exercises and other activities such as carrying out acts of kindness.
pharmaphorum
JANUARY 18, 2022
Two Spanish pharma companies are joining forces to identify new oral treatments for immune-inflammatory skin diseases with high unmet medical needs. It’s an amazing opportunity to put their knowledge and experience in dermatology, together with our expertise in molecular glues to accelerate drug discovery to treat skin diseases.
pharmaphorum
JUNE 2, 2021
Amgen has made a play in a hot area of immunology R&D, paying $400 million upfront to claim rights to an OX40-targeting drug from Kyowa Kirin that is ready for phase 3 testing for atopic dermatitis or eczema. . Kyowa will co-promote the drug in the US if approved, with opt-in rights in some other countries as well.
pharmaphorum
JULY 8, 2022
The COVID-19 pandemic has catalysed significant changes in the way pharma develops drugs, particularly in the clinical trial space. Pharma companies have begun to explore a host of novel digital endpoints that could have far-reaching implications for accelerating drug development and adoption.
pharmaphorum
NOVEMBER 12, 2020
Popit’s technology, which is available in the Netherlands, is clinically validated to reduce the number of missed doses and has been already used by several pharma companies. The company cited a pilot study showing how the system increased adherence in birth control pill users.
Expert insights. Personalized for you.
118 
Let's personalize your content